Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties

Biomedicine and Pharmacotherapy

Volumn 81, Issue , 2016, Pages 7-14

  Olatunji, Opeyemi J ^a   Feng, Yan ^a   Olatunji, Oyenike O ^b   Tang, Jian ^a   Ouyang, Zhen ^a   Su, Zhaoliang ^a  

^a JIANGSU UNIVERSITY   (China)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

6 hydrpxydopamine; Antioxidant; Cordycepin; Cordyceps cicadae; Parkinson's disease; PC12 cells

Indexed keywords

CASPASE 3; CORDYCEPIN; CYTOCHROME C; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NEUROPROTECTIVE AGENT; OXIDOPAMINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; DEOXYADENOSINE DERIVATIVE; NEUROTOXIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORDYCEPS; DRUG ISOLATION; DRUG MECHANISM; DRUG PURIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PC12 CELL LINE; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ENZYME ACTIVATION; LIPID PEROXIDATION; METABOLISM;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; DEOXYADENOSINES; ENZYME ACTIVATION; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MALONDIALDEHYDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEUROPROTECTION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDOPAMINE; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84962408477     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.03.009     Document Type: Article

References (54)

1. MacPhee G., Stewart D. Parkinson's disease. Rev. Clin. Gerontol. 2001, 11:33-49.
2. Moghal S., Rajput A.H., D'Arcy C., Rajput R. Prevalence of movement disorders in elderly community residents. Neuroepidemiology 1994, 13:175-178.
3. Darvas M., Henschen C.W., Palmite R.D. Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease. Neurobiol. Dis. 2014, 65:112-123.
4. Wang Y.M., Xuan Z.H., Tian S., He G.R., Du G.H. Myricitrin attenuates 6-hydroxydopamine-induced mitochondrial damage and apoptosis in PC12 cells via inhibition of mitochondrial oxidation. J. Funct. Food. 2013, 5:337-345.
5. Schapira A.H., Jenner P. Etiology and pathogenesis of Parkinson's disease. Mov. Disord. 2011, 26:1049-1055.
6. Perry G., Taddeo M.A., Nunomura A., Zhu X., Zenteno-Savin T., Drew K.L., Shimohama S., Avila J., Castellani R.J., Smith M.A. Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response. Comp. Biochem. Physiol. Toxicol. Pharmacol. 2002, 133:507-513.
7. Henchicliffe C., Beal M.F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Rev. Neurol. 2008, 4:600-609.
8. Cannon J., Greenamyre J.T. Neurotoxic in vivo models of Parkinson's disease recent advance. Prog. Brain Res. 2010, 184:17-33.
9. Dawson T.M., Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 302:819-822.
10. Kedar N.P. Can we prevent Parkinson's and Alzheimer's disease?. J. Postgrad. Med. 2003, 49:236-245.
11. Beal M.F. Experimental models of Parkinson's disease. Nat Rev. Neurosci. 2001, 2:325-334.
12. Simola N., Morelli M., Carta A.R. The 6-hydroxydopamine model of Parkinson's disease. Neurotox. Res. 2007, 11:151-167.
13. Padiglia A., Medda R., Lorrai A., Biggio G., Sanna E., Floris G. Modulation of 6-hydroxydopamine oxidation by various proteins. Biochem. Pharmacol. 1997, 53:1065-1068.
14. Palumbo A., Napolitano A., Barone P., d'Ischia M. Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6-nitrodopamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration. Chem. Res. Toxicol. 1999, 12:1213-1222.
15. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 2001, 65:135-172.
16. Essa M.M., Vijayan R.K., Castellano-Gonzalez G., Memon M.A., Braidy N., Guillemin G.J. Neuroprotective effect of natural products against Alzheimer's disease. Neurochem. Res. 2012, 37:1829-1842.
17. Houghton P.J., Howes M.J. Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease. Neurosignals 2005, 14:6-22.
18. Essa1 M.M., Braidy N., Bridge W., Subash S., Manivasagam T., Vijayan R.K., Al-Adawi S., Guillemin G.J. Review of natural products on Parkinson's disease pathology. JARCP 2014, 3:127-136.
19. Campos H.C., da Rocha M.D., Viegas F.P., Nicastro P.C., Fossaluzza P.C., Fraga C.A., Barreiro E.J., Viegas C. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson's disease. CNS Neurol. Disord. Drug Targets 2011, 10:239-250.
20. Li B.L. Herbal textuals research on Chan Hua. Chin. J. Med. Appl. Pharm. 1993, 10:21-22.
21. Kuo Y.C., Lin L.C., Don M.J., Liao H.F., Tsai Y.P., Lee G.H., Chou C.J. Cyclodepsipeptide and dioxomorpholine derivatives isolated from the insect-body portion of the fungus Cordyceps cicadae. J. Chin. Med. 2002, 13:209-219.
22. Zhu R., Zheng R., Deng Y., Chen Y., Zhang S. Ergosterol peroxide from Cordyceps cicadae ameliorates TGF-β1-induced activation of kidney fibroblast. Phytomedicine 2014, 21:372-378.
23. Kim H.S., Kim J.Y., Ryu H.S., Shin B.R., Kang J.S., Kim H.M., Kim Y.O., Hong J.T., Kim Y., Han S.B. Phenotypic and functional maturation of dendritic cells induced by polysaccharide isolated from Paecilomyces cicadae. J. Med. Food 2011, 14:847-856.
24. Chen Z.A., Liu G.Y., Hu S.Y. Study on cultivation of Paecilomyces cicadae and its pharmacological function. Acta Mycol. Sin. 1993, 12:13-144.
25. Liu G.Y., Hu S.Y. Comparison of sedative and analgesic effects between Cordyceps cicadae and its cultured product. Chin. J. Med. Appl. Pharm. 1991, 8:4-8.
26. Wang Y., Zhao X.J., Tang F.D. Primary exploring on pharmic effect of Cordyceps cicadae. Zhejiang J. Chin. Tradit. Med. 2001, 36:219-220.
27. Kuo Y.C., Weng S.C., Chou C.J., Chang T.T., Tsai W.J. Activation and proliferation signals in primary human T lymphocytes inhibited by ergosterol peroxide isolated from Cordyceps cicadae. Br. J. Pharmacol. 2003, 140:895-906.
28. Ukai S., Kiho T., Hara C., Morita M., Goto A., Imaizumi N., Hasegawa Y. Polysaccharides in Fungi. XIII. Antitumor activity of various polysaccharides isolated from Dictyophora indusiata, Ganoderma japonicum, Cordyceps cicadae, Auricularia auricula-judae and Auricularia species. Chem. Pharm. Bull. 1983, 31:741-744.
29. Kiho T., Nagai K., Miyamoto I., Watanabe T., Ukai S. Polysaccharides in fungi XXV. Biological activities of two galactomannans from the insect-body portion of Chan Hua (fungus: Cordyceps cicadae). Yakugaku Zasshi 1990, 110:286-288.
30. Yu J.W., Xu H.J., Mo Z.H., Zhu H.L., Mao X.B. Determination of myriocin in natural and cultured Cordyceps cicadae using 9-fluorenylmethyl chloroformate derivatization and high-performance liquid chromatography with UV-detection. Anal. Sci. 2009, 25:855-859.
31. Ge F., Xia C.R., Li C.R., Ding T., Shao Y., Fan M.Z. Analysis of the chemical compositions of Paecilomyces cicadae fermented mycelia and Cordyceps cicadae fruit body. Mycosystema 2007, 26:68-75.
32. Nakamura K., Shinozuka K., Yoshikawa N. Anticancer and antimetastatic effects of cordycepin: an active component of Cordyceps sinensis. J. Pharmacol. Sci. 2015, 127:53-56.
33. Tuli H.S., Sharma A.K., Sandhu S.S., Kashyap D. Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci. 2013, 93:863-869.
34. Ramesh T., Yoo S.K., Kim S.W., Hwang S.Y., Sohn S.H., Kim I.W., Kim S.K. Cordycepin (3'-deoxyadenosine) attenuates age-related oxidative stress and ameliorates antioxidant capacity in rats. Exp. Gerontol. 2012, 47:979-987.
35. Cheng Z., He W., Zhou X., Lv Q., Xu X., Yang S., Zhao C., Guo L. Cordycepin protects against cerebral ischemia/reperfusion injury in vivo and in vitro. Eur. J. Pharmacol. 2011, 664:20-28.
36. Jin M.L., Park S.Y., Kim Y.H., Oh J.I., Lee S.J., Park G. The neuroprotective effects of cordycepin inhibit glutamate-induced oxidative and ER stress-associated apoptosis in hippocampal HT22 cells. Neurotoxicology 2014, 41:102-111.
37. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
38. Gilgun-Sherki Y., Melamed E., Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001, 40:959-975.
39. Blum D., Torch S., Lambeng N., Nissou M.F., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA: dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 2001, 65:135-172.
40. Gong M.F., Xu J.P., Chu Z.Y., Luan J. Effect of Cordyceps sinensis sporocarp on learning-memory in mice. Zhong Yao Cai 2011, 34:]1403-1405.
41. Jin D.Q., Park B.C., Lee J.S., Choi H.D., Lee Y.S., Yang J.H., Kim J.A. Mycelial extract of cordyceps ophioglossoides prevents neuronal cell death and ameliorates beta-amyloid peptide-induced memory deficits in rats. Biol. Pharm. Bull. 2004, 27:1126-1129.
42. Ji D.B., Ye J., Li C.L., Wang Y.H., Zhao J., Cai S.Q. Antiaging effect of Cordyceps sinensis extract. Phytother. Res. 2009, 23:116-122.
43. Li Z., Zhang Z., Zhang J., Jia J., Ding J., Luo R., Liu Z. Cordyceps militaris extract attenuates d-galactose-induced memory impairment in mice. J. Med. Food 2012, 15:1057-1063.
44. Soto-Otero R., Mendez-Alvarez E., Sanchez-Iglesias S., Zubkov F.I., Voskressensky L.G., Varlamov A., de Candia M., Altomare C. Inhibition of 6-hydroxydopamine induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides. Biochem. Pharmacol. 2008, 75:1526-1537.
45. Saito Y., Nishio K., Ogawa Y., Kinumi T., Yoshida Y., Mascuo Y., Niki E. Molecular mechanisms of 6-hydroxydopamine induced cytotoxicity in PC12 cells; involvement of hydrogen peroxide dependent and independent action. Free Radic. Biol. Med. 2007, 42:675-685.
46. Glinka Y., Youdim M.B. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. 1995, 292:329-332.
47. Xu R., Liu J., Chen X., Xu F., Xie Q., Yu H., Guo Q., Zhou X., Jin Y. Ribozyme-mediated inhibition of caspase-3 activity reduces apoptosis induced by 6-hydroxydopamine in PC12 cells. Brain Res. 2001, 899:10-19.
48. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol. Lett. 2004, 149:19-23.
49. Cai J., Yang J., Jones D.P. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim. Biophys. Acta 1998, 1366:139-149.
50. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Green D.R., Martin S.J. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 1999, 144:281-292.
51. Porter A.G., Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999, 6:99-104.
52. Wang Y.H., Xuan Z.H., Tian S., He G.R., Du G.H. Myricitrin attenuates 6-hydroxydopamine-induced mitochondrial damage and apoptosis in PC12 cells via inhibition of mitochondrial oxidation. J. Funct. Food 2013, 5:337-345.
53. Xiao L., Ge Y., Sun L., Xu X., Xie P., Zhan M., Wang M., Dong Z., Li J., Duan S., Liu F., Xiao P. Cordycepin inhibits albumin-induced epithelial-mesenchymal transition of renal tubular epithelial cells by reducing reactive oxygen species production. Free Radic. Res. 2012, 46:174-183.
54. He Y.T., Zhang X.L., Xie Y.M., Xu Y.X., Li J.R. Extraction and antioxidant property in vitro of codycepin in artificially cultivated Cordyceps militaris. Adv. Mater. Res. 2013, 750-752:1593-1596.